HRP20030046B1 - Farmaceutski pripravci za tretman bolnih, upalnih i ulcerativnih stanja vlažnih epitelnih površina kao što su mukozitis, stomatitis i behcetov sindrom - Google Patents

Farmaceutski pripravci za tretman bolnih, upalnih i ulcerativnih stanja vlažnih epitelnih površina kao što su mukozitis, stomatitis i behcetov sindrom

Info

Publication number
HRP20030046B1
HRP20030046B1 HR20030046A HRP20030046A HRP20030046B1 HR P20030046 B1 HRP20030046 B1 HR P20030046B1 HR 20030046 A HR20030046 A HR 20030046A HR P20030046 A HRP20030046 A HR P20030046A HR P20030046 B1 HRP20030046 B1 HR P20030046B1
Authority
HR
Croatia
Prior art keywords
epitellium
mucositis
stomatitis
inflammatory
patients
Prior art date
Application number
HR20030046A
Other languages
English (en)
Croatian (hr)
Inventor
Mastrodonato Marco
Original Assignee
Sinclair Pharmaceuticals Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sinclair Pharmaceuticals Limited filed Critical Sinclair Pharmaceuticals Limited
Publication of HRP20030046A2 publication Critical patent/HRP20030046A2/xx
Publication of HRP20030046B1 publication Critical patent/HRP20030046B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
HR20030046A 2000-07-28 2001-07-18 Farmaceutski pripravci za tretman bolnih, upalnih i ulcerativnih stanja vlažnih epitelnih površina kao što su mukozitis, stomatitis i behcetov sindrom HRP20030046B1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2000MI001732A IT1318649B1 (it) 2000-07-28 2000-07-28 Composizioni farmaceutiche per il trattamento di mucositi e stomatiti.
PCT/EP2001/008303 WO2002009637A2 (en) 2000-07-28 2001-07-18 Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome

Publications (2)

Publication Number Publication Date
HRP20030046A2 HRP20030046A2 (en) 2004-04-30
HRP20030046B1 true HRP20030046B1 (hr) 2011-08-31

Family

ID=11445589

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20030046A HRP20030046B1 (hr) 2000-07-28 2001-07-18 Farmaceutski pripravci za tretman bolnih, upalnih i ulcerativnih stanja vlažnih epitelnih površina kao što su mukozitis, stomatitis i behcetov sindrom

Country Status (25)

Country Link
US (1) US20020173485A1 (enExample)
EP (1) EP1313489B1 (enExample)
JP (1) JP2004505028A (enExample)
KR (1) KR100761051B1 (enExample)
CN (1) CN1198625C (enExample)
AR (1) AR030068A1 (enExample)
AT (1) ATE289512T1 (enExample)
AU (2) AU2002212113B2 (enExample)
BR (1) BRPI0112962B8 (enExample)
CA (1) CA2424346C (enExample)
CZ (1) CZ301461B6 (enExample)
DE (1) DE60109044T2 (enExample)
ES (1) ES2236324T3 (enExample)
HR (1) HRP20030046B1 (enExample)
IT (1) IT1318649B1 (enExample)
MX (1) MXPA03000712A (enExample)
MY (1) MY130477A (enExample)
NO (1) NO329574B1 (enExample)
NZ (1) NZ523832A (enExample)
PL (1) PL204397B1 (enExample)
PT (1) PT1313489E (enExample)
RU (1) RU2272636C2 (enExample)
UA (1) UA79075C2 (enExample)
WO (1) WO2002009637A2 (enExample)
ZA (1) ZA200300712B (enExample)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7544348B2 (en) 2001-02-15 2009-06-09 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
US7547433B2 (en) 2001-02-15 2009-06-16 Access Pharmaceuticals, Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
US6585997B2 (en) 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
AU2003230321B8 (en) 2002-05-09 2009-07-30 Medigenes A pharmaceutical composition for treatment of wounds containing blood plasma or serum
WO2004064850A1 (en) * 2003-01-23 2004-08-05 Ml Laboratories Plc Antiviral composition comprising a sulphated glucose polymer and a bacteriostatic agent
GB0312485D0 (en) * 2003-05-30 2003-07-09 Dodson & Horrell Horse food composition
ITMI20031291A1 (it) 2003-06-25 2004-12-26 Ricerfarma Srl Uso di acido ialuronico per la preparazione di composizioni per il trattamento di afte del cavo orale.
AU2003265624B2 (en) * 2003-08-21 2011-03-31 Abeona Therapeutics Inc. Liquid formulations for the prevention and treatment of mucosal diseases and disorders
US7323184B2 (en) 2005-08-22 2008-01-29 Healagenics, Inc. Compositions and methods for the treatment of wounds and the reduction of scar formation
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
WO2008027904A2 (en) * 2006-08-28 2008-03-06 Rexaderm, Inc. Dry wound dressing and drug delivery system
KR100758636B1 (ko) * 2006-12-19 2007-09-13 고려대학교 산학협력단 생체 점막 점착성 고분자 접합체 및 이의 제조방법
US20090143343A1 (en) 2007-11-13 2009-06-04 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
KR101245604B1 (ko) 2007-11-13 2013-03-21 메리테이지 파마, 인크. 코르티코스테로이드 조성물
US20090264392A1 (en) * 2008-04-21 2009-10-22 Meritage Pharma, Inc. Treating eosinophilic esophagitis
GB0813589D0 (en) * 2008-07-24 2008-09-03 Sinclair Pharmaceuticals Ltd Composition
WO2010136872A2 (en) * 2009-05-25 2010-12-02 Pharcoterm S.R.L. Use of a glycosaminoglycan fixed combination and chewable composition comprising said fixed combination
US10327467B2 (en) 2010-04-14 2019-06-25 Altria Client Services Llc Preformed smokeless tobacco product
WO2012064339A1 (en) * 2010-11-12 2012-05-18 Colgate-Palmolive Company Oral care product and methods of use and manufacture thereof
ES2388281B1 (es) 2010-12-27 2013-10-01 Laboratorios Viñas S.A. Composición farmacéutica que comprende ácido hialurónico y un compuesto de zinc y pastilla con palito y procedimiento para preparación correspondientes
ITMI20110954A1 (it) * 2011-05-26 2012-11-27 Professional Dietetics Srl Combinazioni per il trattamento delle mucositi vaginali o rettali
US10799548B2 (en) 2013-03-15 2020-10-13 Altria Client Services Llc Modifying taste and sensory irritation of smokeless tobacco and non-tobacco products
EP3079656B8 (en) * 2013-10-16 2020-02-26 Quest Products, LLC Treating mucosal lesions with hyaluronan delivered from an adhering troche
CN105342987A (zh) * 2015-12-04 2016-02-24 亚飞（上海）生物医药科技有限公司 一种凝胶及其制备方法和应用
ITUA20161822A1 (it) * 2016-03-18 2017-09-18 Indena Spa Composizioni utili nella prevenzione e/o nel trattamento di patologie del cavo orale, delle prime vie aeree e dell’esofago
EP3492073B1 (en) * 2016-07-27 2022-04-27 Ritapharma, Co., Ltd. Oral mucosa application material and method for producing same
IT201600079773A1 (it) * 2016-07-29 2018-01-29 Matteo Bevilacqua Composizioni contenenti oligosaccaridi di acido ialuronico (HA4), condroitin solfato (CS2-4) ed eparan solfato (HS2-4), triterpeni pentaciclici e derivati per uso medico curativo e metodo per la preparazione di tali composizioni.
CN106176863A (zh) * 2016-08-04 2016-12-07 陈广圣 一种医用抗菌剂
CN107802641A (zh) * 2016-09-09 2018-03-16 李明典 口腔软组织(牙龈、粘膜)抗发炎酸痛剂
EP3459368B1 (en) * 2017-09-20 2025-08-20 Geophyt S.r.L. Food integrator for antineoplastic therapies
CN109331023A (zh) * 2018-11-12 2019-02-15 沈阳药科大学 甘草次酸的医药用途
KR102475125B1 (ko) 2019-08-07 2022-12-07 고려대학교 산학협력단 일산화질소 복합체를 포함하는 구강 점막염 치료용 조성물 및 구강 점막염 치료제
AU2020372237B2 (en) * 2019-10-25 2024-10-24 Mucocort Ab Treatment of inflammatory condition in mucous membrane or skin
IT202100011879A1 (it) * 2021-05-10 2022-11-10 Aurora Biofarma S R L Composizione orale per il trattamento delle esofagiti
CN116370333A (zh) * 2021-12-24 2023-07-04 太阳星光齿磨公司 含β-甘草次酸的组合物

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2092442A (en) * 1981-02-06 1982-08-18 Biorex Laboratories Ltd Pharmaceutical composition for treating diseases of the oral cavity, containing glycyrrhetinic acid or a derivative thereof
EP0444492A1 (en) * 1990-02-21 1991-09-04 RICERFARMA Srl Topically administered compositions based on high molecular weight hyaluronic acid for treating inflammations of the oral cavity, and for oral cavity hygiene and cosmetic treatment

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA82361B (en) * 1981-02-06 1982-12-29 Biorex Laboratories Ltd Pharmaceutical composition for treating diseases of the oral cavity
JPS6117510A (ja) * 1984-07-03 1986-01-25 Toyobo Co Ltd 口腔粘膜適用徐放性ニフエジピン製剤
JPS6440423A (en) * 1987-08-05 1989-02-10 Kyukyu Yakuhin Kogyo Kk Patch for mucosa in oral cavity
US4965253A (en) * 1987-10-14 1990-10-23 University Of Florida Viscoelastic material for ophthalmic surgery
FR2720937B1 (fr) * 1994-06-08 1997-03-28 Oreal Composition cosmétique ou dermatologique sous forme de dispersion, aqueuse et stable, de particules de gel cubique à base de phytantriol et contenant un agent tensioactif à chaîne grasse en tant qu'agent dispersant et stabilisant.
JPH09169652A (ja) * 1995-12-18 1997-06-30 Lion Corp 水性液状組成物
JPH10182390A (ja) * 1996-12-25 1998-07-07 Lion Corp 口腔用組成物
JP2000178185A (ja) * 1998-12-18 2000-06-27 Lion Corp 口腔粘膜付着型徐放性錠剤

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2092442A (en) * 1981-02-06 1982-08-18 Biorex Laboratories Ltd Pharmaceutical composition for treating diseases of the oral cavity, containing glycyrrhetinic acid or a derivative thereof
EP0444492A1 (en) * 1990-02-21 1991-09-04 RICERFARMA Srl Topically administered compositions based on high molecular weight hyaluronic acid for treating inflammations of the oral cavity, and for oral cavity hygiene and cosmetic treatment

Also Published As

Publication number Publication date
PL362921A1 (en) 2004-11-02
UA79075C2 (uk) 2007-05-25
KR20030069979A (ko) 2003-08-27
NO20030411L (no) 2003-01-27
BRPI0112962B8 (pt) 2021-05-25
HRP20030046A2 (en) 2004-04-30
AR030068A1 (es) 2003-08-13
ES2236324T3 (es) 2005-07-16
ITMI20001732A1 (it) 2002-01-28
DE60109044D1 (de) 2005-03-31
US20020173485A1 (en) 2002-11-21
CZ301461B6 (cs) 2010-03-10
EP1313489B1 (en) 2005-02-23
KR100761051B1 (ko) 2007-10-04
MY130477A (en) 2007-06-29
PT1313489E (pt) 2005-05-31
AU1211302A (en) 2002-02-13
ZA200300712B (en) 2004-02-09
NO329574B1 (no) 2010-11-15
ITMI20001732A0 (it) 2000-07-28
EP1313489A2 (en) 2003-05-28
DE60109044T2 (de) 2005-07-21
WO2002009637A3 (en) 2002-12-05
AU2002212113B2 (en) 2006-01-12
RU2272636C2 (ru) 2006-03-27
NO20030411D0 (no) 2003-01-27
CA2424346A1 (en) 2002-02-07
CN1198625C (zh) 2005-04-27
PL204397B1 (pl) 2010-01-29
CN1474700A (zh) 2004-02-11
JP2004505028A (ja) 2004-02-19
ATE289512T1 (de) 2005-03-15
IT1318649B1 (it) 2003-08-27
CA2424346C (en) 2010-03-09
BR0112962B1 (pt) 2013-12-31
WO2002009637A2 (en) 2002-02-07
NZ523832A (en) 2003-09-26
HK1059215A1 (en) 2004-06-25
MXPA03000712A (es) 2004-11-01
BR0112962A (pt) 2003-06-24

Similar Documents

Publication Publication Date Title
HRP20030046B1 (hr) Farmaceutski pripravci za tretman bolnih, upalnih i ulcerativnih stanja vlažnih epitelnih površina kao što su mukozitis, stomatitis i behcetov sindrom
DK1898876T3 (da) Mucoadhæsive xyloglucanholdige fprmuleringer anvendelige i medicinske anordninger og i farmaceutiske former
AU2016293004B2 (en) Stuffy nose deblocking composition having antiviral activity
BRPI0108435B8 (pt) formulação e uso de entecavir de baixa dose
ATE323473T1 (de) Pharmazeutische zusammensetzungen enthaltend resveratrol und verwendungen davon
ZA200305412B (en) 4-fluoro-N-indan-2-yl benzamide and its use as pharmaceutical.
NO20001567D0 (no) Bioadhesive sammensetninger og fremgangsmåter for topisk administrering av aktive midler
NO312225B2 (no) Farmasoytiske preparater av fluoxetin
PT1227820E (pt) Acidos oligossacarido-aldonicos e sua utilizacao topica
ES2080844T3 (es) Composiciones administradas topicamente basadas en acido hialuronico de alto peso molecular para el tratamiento de las inflamaciones de la cavidad oral y para la higiene y el tratamiento cosmetico de la cavidad oral.
SE9704833D0 (sv) New formulation
JP2016153436A (ja) 微生物感染の治療に使用するためのタマリンド種子多糖
DK165903C (da) Farmaceutisk praeparat mod acne
HUP0301506A2 (hu) Gyógyászati készítmények nedves hámfelületek fájdalmas, gyulladásos vagy fekélyes állapotai, így például nyálkahártyagyulladás, szájgyulladás és behcet-tünetcsoport kezelésére
ATE311928T1 (de) (-)-pseudoephedrin als sympathomimetisches arzneimittel
ATE249820T1 (de) Zubereitung für warzen
FI932654A0 (fi) Hydroxamsyraderivat, som hindrar lipoxigenas
MD2516B1 (en) Anti-inflammatory, antiseptic and antimycotic medicament in the form of gel
EP0753309A2 (en) Preparation of lactoferrin (or analogous proteins) and desferrioxamine methanesulfonate (or other metal ion chelators) for the therapy of viral infectious diseases
BRPI0414454A (pt) agentes antibacterianos
IT1277118B1 (it) Composizioni farmaceutiche per il trattamento delle epatopatie croniche
JO2370B1 (en) Pharmaceutical formulations for the treatment of painful, inflamed and ulcerated conditions of wet epithelial surfaces such as mucositis, stomatitis and Behçet syndrome
FI20031793A0 (fi) Uusi anti-proliferatiivinen farmaseuttinen koostumus
FR2832925B1 (fr) Utilisation de derives de l'acide 4-oxobutanoique dans le traitement de l'inflammation
AR029071A1 (es) Uso de sacrridos sulfatados y de sus sales o complejos derivados para la preparacion de composiciones farmaccuticas de uso tnpico, composiciones medicinales que los contienen y sus mctodos de preparacinn

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
B1PR Patent granted
PNAN Change of the applicant name, address/residence

Owner name: SINCLAIR PHARMACEUTICALS LIMITED, GB

PPPP Transfer of rights

Owner name: ALLIANCE PHARMACEUTICALS LIMITED, GB

ODRP Renewal fee for the maintenance of a patent

Payment date: 20190513

Year of fee payment: 19

ODRP Renewal fee for the maintenance of a patent

Payment date: 20200625

Year of fee payment: 20

PB20 Patent expired after termination of 20 years

Effective date: 20210718